State of Alaska, Department of Revenue - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$202
-4.3%
7,130
-1.7%
0.00%
-33.3%
Q4 2022$211
-99.9%
7,251
-1.5%
0.00%0.0%
Q3 2022$194,000
-48.3%
7,358
-12.9%
0.00%
-40.0%
Q2 2022$375,000
-4.1%
8,449
+6.8%
0.01%
+25.0%
Q1 2022$391,000
-4.4%
7,909
-1.7%
0.00%0.0%
Q4 2021$409,000
-12.8%
8,049
-4.3%
0.00%
-20.0%
Q3 2021$469,000
+35.9%
8,409
+4.1%
0.01%
+66.7%
Q2 2021$345,000
+5.5%
8,074
+2.8%
0.00%
-25.0%
Q1 2021$327,000
-22.1%
7,854
-13.0%
0.00%
-20.0%
Q4 2020$420,000
-12.7%
9,024
-20.3%
0.01%
-16.7%
Q3 2020$481,000
+7.8%
11,324
+21.7%
0.01%0.0%
Q2 2020$446,000
+3.5%
9,304
-0.9%
0.01%
-14.3%
Q1 2020$431,000
-5.9%
9,384
+22.8%
0.01%
+16.7%
Q4 2019$458,000
+4.3%
7,639
-1.7%
0.01%0.0%
Q3 2019$439,000
+125.1%
7,771
+121.6%
0.01%
+100.0%
Q2 2019$195,000
+11.4%
3,507
+0.9%
0.00%0.0%
Q1 2019$175,000
+17.4%
3,477
-6.5%
0.00%0.0%
Q4 2018$149,000
-40.4%
3,717
+3.0%
0.00%
-25.0%
Q3 2018$250,000
+22.5%
3,607
+33.5%
0.00%0.0%
Q2 2018$204,000
+43.7%
2,7020.0%0.00%
+33.3%
Q1 2018$142,000
+57.8%
2,702
+59.7%
0.00%
+50.0%
Q4 2017$90,000
-10.0%
1,6920.0%0.00%
-60.0%
Q3 2017$100,000
-20.0%
1,692
+6.3%
0.01%
-44.4%
Q2 2017$125,000
+71.2%
1,592
+78.9%
0.01%
+80.0%
Q1 2017$73,000
+7.4%
890
+3.5%
0.01%
-28.6%
Q4 2016$68,0008600.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders